Elevated plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-α -308 G/A polymorphism

Psychosomatic Medicine

Volumn 66, Issue 4, 2004, Pages 501-506

  Jeanmonod, Pascal ^a   Von Känel, Roland ^a,b   Maly, Friedrich E ^c   Fischer, Joachim E ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

C reactive protein; Cardiovascular disease; Exhaustion; Polymorphism; Tumor necrosis factor

Indexed keywords

ADENINE; C REACTIVE PROTEIN; GUANIDINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DOSE RESPONSE; EMPLOYEE; ENVIRONMENTAL FACTOR; EXHAUSTION; FEMALE; HEREDITY; HUMAN; IMMUNOASSAY; INDUSTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

ADULT; ALLELES; C-REACTIVE PROTEIN; CHRONIC DISEASE; CORONARY DISEASE; FATIGUE; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; MALE; OCCUPATIONAL DISEASES; POLYMORPHISM, GENETIC; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242745073     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000130903.78444.7d     Document Type: Article

References (36)

1. Appels A. Mental precursors of myocardial infarction. Br J Psychiatry 1990;156:465-71.
2. Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988;9:758-64.
3. Kop WJ, Appels AP, Mendes de Leon CF, de Swart HB, Bar FW. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994;56:281-7.
4. Kop WJ, Appels AP, Mendes de Leon CF, Bar FW. The relationship between severity of coronary artery disease and vital exhaustion. J Psychosom Res 1996;40:397-405.
5. Appels A, Bar FW, Bar J, Bruggeman C, de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000;62:601-5.
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
7. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001;88:10-5K.
8. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149-53.
9. Koenig W. Inflammation and coronary heart disease: an overview. Cardiol Rev 2001;9:31-5.
10. Eliasen LT, Rekdal O, Svensen JS, Osterud B. TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood. Thromb Haemost 2000;83:598-604.
11. Andreotti F, Porto I, Crea F, Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 2002;87:107-12.
12. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998;28:59-66.
13. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 2000;100:263-9.
14. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999;99:861-6.
15. Keso T, Perola M, Laippala P, Ilveskoski E, Kunnas TA, Mikkelsson J, Penttila A, Hurme M, Karhunen PJ. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 2001;154:691-7.
16. Simmonds RE, Hermida J, Rezende SM, Lane DA. Haemostatic genetic risk factors in arterial thrombosis. Thromb Haemost 2001;86:374-85.
17. Vischetti M, Zito F, Donati MB, Iacoviello L. Analysis of gene-environment interaction in coronary heart disease: fibrinogen polymorphisms as an example. Ital Heart J 2002;3:18-23.
18. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113:401-6.
19. Hamet P, Tremblay J. Genetic determinants of the stress response in cardiovascular disease. Metabolism 2002;51(suppl 1):15-24.
20. Ravaja N, Raikkonen K, Lyytinen H, Lehtimaki T, Keltikangas-Jarvinen L. Apolipoprotein E phenotypes and cardiovascular responses to experimentally induced mental stress in adolescent boys. J Behav Med 1997;20:571-87.
21. Li GH, Faulhaber HD, Rosenthal M, Schuster H, Jordan J, Timmermann B, Hoehe MR, Luft FC, Busjahn A. Beta-2 adrenergic receptor gene variations and blood pressure under stress in normal twins. Psychophysiology 2001;38:485-9.
22. Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ, Kuhn CM, Lewis JG, Schanberg SM, Stafford-Smith M, Suarez EC, Clary GL, Svenson IK, Siegler IC. Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med 2001;63:300-5.
23. Krantz DS, McCeney MK. Effects of psychological and social factors on organic disease: a critical assessment of research on coronary heart disease. Annu Rev Psychol 2002;53:341-69.
24. Schnorpfeil P. Allostatic load, vital exhaustion, and job characteristics in employees of the manufacturing industry. Zurich: University Zurich; 2001.
25. Michael YL, Colditz GA, Coakley E, Kawachi I. Health behaviors, social networks, and healthy aging: cross-sectional evidence from the Nurses' Health Study. Qual Life Res 1999;8:711-22.
26. Jonsson D, Rosengren A, Dotevall A, Lappas G, Wilhelmsen L. Job control, job demands and social support at work in relation to cardiovascular risk factors in MONICA 1995, Goteborg. J Cardiovasc Risk 1999;6:379-85.
27. Kopp MS, Falger PR, Appels A, Szedmak S. Depressive symptomatology and vital exhaustion are differentially related to behavioral risk factors for coronary artery disease. Psychosom Med 1998;60:752-8.
28. Raikkonen K, Lassila R, Keltikangas-Jarvinen L, Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol 1996;16:363-7.
29. Kop WJ, Hamulyak K, Pernot C, Appels A. Relationship of blood coagulation and fibrinolysis to vital exhaustion. Psychosom Med 1998;60:352-8.
30. von Kanel R, Frey K, Fischer JE. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects. Scand Cardiovasc J. 2004;38:28-32.
31. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
32. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
33. Ridker PM, Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Invest Med 1998;46:391-5.
34. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-9.
35. Kop WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med 1999;61:476-87.
36. van Diest R, Appels A. Vital exhaustion and depression: a conceptual study. J Psychosom Res 1991;35:535-44.